3rd Quarter - Report

ORGANOGENESIS INC. for ORGANOGENESIS INC.

Firm
Client
Income
—
Expenses
$60,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare reimbursement policy for chronic wound healing products Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product

LobbyistCovered position, as disclosed
ARTHUR-PAUL PETROSINELLI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Medical device excise tax H.R.2207 and S.692 (Protect Medical Innovation Act of 2019), all provisions

LobbyistCovered position, as disclosed
ARTHUR-PAUL PETROSINELLI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 692 (116th), H.R. 2207 (116th)

Veterans VET

Procurement of chronic wound healing products

LobbyistCovered position, as disclosed
ARTHUR-PAUL PETROSINELLI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Defense DEF

Federal research and development funding regarding regenerative medicine products

LobbyistCovered position, as disclosed
ARTHUR-PAUL PETROSINELLI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Food and Drug Administration policy on chronic wound healing products

LobbyistCovered position, as disclosed
ARTHUR-PAUL PETROSINELLI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.